RA Capital has steamed ahead with its third private equity fundraise in two years to reach an impressive $880m final close. The post Fundraising surge continues at RA Capital as firm seals $880m for third
Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer
Evergreen investment fund AlleyCorp has launched a $100m healthcare investment vehicle targeting early-stage VC and incubation-stage deals. The post AlleyCorp launches $100m healthcare investment fund targeting NYC startups first appeared on AltAssets Private Equity News.
Thomas H Lee Partners has hired Martis Capital founding partner Shahab Vagefi as a managing director in its healthcare vertical. The post Thomas H Lee Partners brings in Martis Capital founding partner as healthcare managing
Audax Private Equity has bought a majority stake in healthcare-focused mounts, clamps and stands specialist GCX. The post Audax takes stake in medical mount, clamps and stands specialist GCX first appeared on AltAssets Private Equity
Private equity pair Nordic Capital and Avista Capital Partners has agreed to sell Swiss pharma business Acino to Abu Dhabi sovereign wealth investor ADQ. The post Abu Dhabi sovereign arm buys Nordic Capital, Avista-backed pharma
Healthcare-focused private equity house Amulet Capital Partners has hit a $650m final close for its oversubscribed second fundraise. The post Healthcare-focused Amulet Capital clears target with $650m Fund II final close first appeared on AltAssets
Buyout house Astorg and Goldman Sachs Asset Management have received a binding €1.8bn offer for HRA Pharma from trade buyer Perrigo. The post Astorg, Goldman Sachs AM get €1.8bn binding offer for HRA Pharma first
Private equity major GTCR has promoted John Kos to managing director after 15 years with the firm. The post GTCR promotes long-serving exec Kos to managing director first appeared on AltAssets Private Equity News.
Avista Capital Partners has revealed its succession strategy as co-founder Tom Dean prepares to step away from his co-CEO position. The post Succession strategy revealed at Avista Capital as co-founder Dean prepares co-CEO exit first
Healthcare focused private equity house Avista Capital Partners has agreed to sell consumer healthcare provider Arcadia Consumer Healthcare to investment firm Bansk Group. The post Avista Capital Partners to sell Arcadia Consumer Healthcare to Bansk
Healthcare-focused buyout house ArchiMed has closed its oversubscribed third fund on €650m despite receiving €1.3bn in the virtual raise. MED III has beat its target of €500m and doubled the size of its predecessor MED
Global buyout major TA Associates has hired five new vice presidents to be based in Boston and Menlo Park. The post TA Associates follows rapid $12.5bn fundraise with five senior hires first appeared on AltAssets
SLR is expecting more than $1bn of capital to be available for its healthcare direct lending funds after leverage, following an initial close of $480m in equity commitments. The fund is expected to hold its
Baird Capital, the direct dealmaking arm of investment banking giant Baird, has held a $340m final close for its second global fund, just three months after capping off its record venture capital fundraise. The post
European healthcare investment specialist GHO Capital has raced to a €2bn final close for its third flagship fund. The post GHO Capital races to €2bn fund close in just four months, well above €1.25bn target
Shore Capital Partners has passed the $2bn mark for capital under management thanks to a trio of new fund closes. The post Shore Capital soars past $2bn AUM thanks to triple fund close, including debut
Software and data-focused Vista Equity Partners has driven AI-enabled healthcare provider Olive's valuation to $4bn to continue a massive funding surge for the business since the start of the Covid-19 pandemic. The post Vista Equity Partners
Vistria Group has sealed a powerful return to fundraising by striking a $2.68bn hard cap final close for its fourth flagship fund, just 18 months after closing its predecessor vehicle. The post Obama campaign treasurer
Former Fidelity Investments arm Eight Roads has launched a $400m China-focused healthcare fund. The post Eight Roads launches $400m China healthcare investment fund first appeared on AltAssets Private Equity News.
